Structure

Physi-Chem Properties

Molecular Weight:  1276.59
Volume:  1234.753
LogP:  2.642
LogD:  1.533
LogS:  -3.532
# Rotatable Bonds:  17
TPSA:  403.34
# H-Bond Aceptor:  26
# H-Bond Donor:  12
# Rings:  10
# Heavy Atoms:  26

MedChem Properties

QED Drug-Likeness Score:  0.037
Synthetic Accessibility Score:  7.315
Fsp3:  0.781
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.299
MDCK Permeability:  0.00023527606390416622
Pgp-inhibitor:  0.061
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.981
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.101
Plasma Protein Binding (PPB):  70.52872467041016%
Volume Distribution (VD):  0.298
Pgp-substrate:  14.966919898986816%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.07
CYP2C19-inhibitor:  0.001
CYP2C19-substrate:  0.083
CYP2C9-inhibitor:  0.0
CYP2C9-substrate:  0.03
CYP2D6-inhibitor:  0.016
CYP2D6-substrate:  0.039
CYP3A4-inhibitor:  0.251
CYP3A4-substrate:  0.005

ADMET: Excretion

Clearance (CL):  0.232
Half-life (T1/2):  0.533

ADMET: Toxicity

hERG Blockers:  0.211
Human Hepatotoxicity (H-HT):  0.225
Drug-inuced Liver Injury (DILI):  0.393
AMES Toxicity:  0.068
Rat Oral Acute Toxicity:  0.088
Maximum Recommended Daily Dose:  0.949
Skin Sensitization:  0.703
Carcinogencity:  0.035
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.797

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC124828

Natural Product ID:  NPC124828
Common Name*:   Jenisseensoside C/D
IUPAC Name:   (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-4-formyl-8-hydroxy-8a-[(2S,3R,4S,5R,6R)-4-hydroxy-5-[(E)-3-(4-methoxyphenyl)prop-2-enoyl]oxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxycarbonyl-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid
Synonyms:   Jenisseensoside C/D
Standard InCHIKey:  OZOKLZWUTXESGO-BBHDCDGUSA-N
Standard InCHI:  InChI=1S/C64H92O26/c1-28-40(69)42(71)46(75)54(82-28)89-52-48(77)49(86-39(68)17-12-30-10-13-31(81-9)14-11-30)29(2)83-56(52)90-58(80)64-23-22-59(3,4)24-33(64)32-15-16-36-60(5)20-19-38(61(6,27-66)35(60)18-21-62(36,7)63(32,8)25-37(64)67)85-57-51(45(74)44(73)50(87-57)53(78)79)88-55-47(76)43(72)41(70)34(26-65)84-55/h10-15,17,27-29,33-38,40-52,54-57,65,67,69-77H,16,18-26H2,1-9H3,(H,78,79)/b17-12+/t28-,29+,33-,34+,35+,36+,37+,38-,40-,41-,42+,43-,44-,45-,46+,47+,48-,49-,50-,51+,52+,54-,55-,56-,57+,60-,61-,62+,63+,64+/m0/s1
SMILES:  OC[C@H]1O[C@@H](O[C@H]2[C@@H](O[C@@H]([C@H]([C@@H]2O)O)C(=O)O)O[C@H]2CC[C@]3([C@H]([C@]2(C)C=O)CC[C@@]2([C@@H]3CC=C3[C@@]2(C)C[C@H]([C@@]2([C@H]3CC(C)(C)CC2)C(=O)O[C@@H]2O[C@H](C)[C@@H]([C@@H]([C@H]2O[C@@H]2O[C@@H](C)[C@@H]([C@H]([C@H]2O)O)O)O)OC(=O)/C=C/c2ccc(cc2)OC)O)C)C)[C@@H]([C@H]([C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL509232
PubChem CID:   44576216
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11017 Silene fortunei Species Caryophyllaceae Eukaryota n.a. n.a. n.a. PMID[12444678]
NPO11017 Silene fortunei Species Caryophyllaceae Eukaryota n.a. n.a. n.a. PMID[9917300]
NPO11017 Silene fortunei Species Caryophyllaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11017 Silene fortunei Species Caryophyllaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11017 Silene fortunei Species Caryophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10820 Galium spurium Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10187 Protoblastenia incrustans Species Psoraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT15 Cell Line Jurkat Homo sapiens FC = 9.0 n.a. PMID[543705]
NPT15 Cell Line Jurkat Homo sapiens Activity = 1.36 n.a. PMID[543705]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC124828 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8882 High Similarity NPC469772
0.8882 High Similarity NPC100925
0.8882 High Similarity NPC135334
0.8882 High Similarity NPC469777
0.8882 High Similarity NPC469776
0.8882 High Similarity NPC469778
0.8882 High Similarity NPC295941
0.8882 High Similarity NPC469773
0.8882 High Similarity NPC469775
0.8882 High Similarity NPC32723
0.8882 High Similarity NPC469774
0.8721 High Similarity NPC471871
0.8683 High Similarity NPC329960
0.8683 High Similarity NPC150893
0.8683 High Similarity NPC295408
0.8663 High Similarity NPC13989
0.8655 High Similarity NPC471870
0.8642 High Similarity NPC329657
0.8613 High Similarity NPC195972
0.8596 High Similarity NPC189704
0.858 High Similarity NPC326278
0.8547 High Similarity NPC476067
0.8547 High Similarity NPC475121
0.8539 High Similarity NPC299855
0.8539 High Similarity NPC96194
0.8538 High Similarity NPC477466
0.8538 High Similarity NPC477473
0.8538 High Similarity NPC477469
0.8538 High Similarity NPC477471
0.8537 High Similarity NPC69425
0.8529 High Similarity NPC327694
0.8514 High Similarity NPC475613
0.848 Intermediate Similarity NPC102465
0.848 Intermediate Similarity NPC318472
0.8471 Intermediate Similarity NPC471873
0.8452 Intermediate Similarity NPC471878
0.8443 Intermediate Similarity NPC477467
0.8412 Intermediate Similarity NPC471869
0.8407 Intermediate Similarity NPC475299
0.8385 Intermediate Similarity NPC111466
0.8383 Intermediate Similarity NPC477472
0.8383 Intermediate Similarity NPC477470
0.8383 Intermediate Similarity NPC477474
0.8352 Intermediate Similarity NPC112708
0.8352 Intermediate Similarity NPC473630
0.8343 Intermediate Similarity NPC472639
0.8343 Intermediate Similarity NPC472638
0.8333 Intermediate Similarity NPC40085
0.8333 Intermediate Similarity NPC264270
0.8324 Intermediate Similarity NPC473776
0.8324 Intermediate Similarity NPC473205
0.8306 Intermediate Similarity NPC473711
0.8297 Intermediate Similarity NPC230670
0.8297 Intermediate Similarity NPC71385
0.8286 Intermediate Similarity NPC472803
0.828 Intermediate Similarity NPC131405
0.8266 Intermediate Similarity NPC100333
0.8249 Intermediate Similarity NPC186800
0.8249 Intermediate Similarity NPC470667
0.8246 Intermediate Similarity NPC211777
0.8229 Intermediate Similarity NPC160818
0.8229 Intermediate Similarity NPC169299
0.8218 Intermediate Similarity NPC469419
0.8216 Intermediate Similarity NPC470197
0.8216 Intermediate Similarity NPC282474
0.8216 Intermediate Similarity NPC470200
0.8216 Intermediate Similarity NPC470195
0.8216 Intermediate Similarity NPC470193
0.8216 Intermediate Similarity NPC470198
0.8216 Intermediate Similarity NPC470194
0.8216 Intermediate Similarity NPC316274
0.8216 Intermediate Similarity NPC470196
0.8208 Intermediate Similarity NPC475779
0.8204 Intermediate Similarity NPC119252
0.8202 Intermediate Similarity NPC66820
0.8202 Intermediate Similarity NPC176246
0.8202 Intermediate Similarity NPC76112
0.8202 Intermediate Similarity NPC170018
0.8202 Intermediate Similarity NPC92403
0.8198 Intermediate Similarity NPC198047
0.8193 Intermediate Similarity NPC473719
0.8192 Intermediate Similarity NPC262386
0.8182 Intermediate Similarity NPC470330
0.8171 Intermediate Similarity NPC82602
0.8167 Intermediate Similarity NPC85316
0.8167 Intermediate Similarity NPC197357
0.8166 Intermediate Similarity NPC160882
0.8161 Intermediate Similarity NPC99216
0.815 Intermediate Similarity NPC146991
0.814 Intermediate Similarity NPC207978
0.8136 Intermediate Similarity NPC148185
0.8136 Intermediate Similarity NPC477617
0.8136 Intermediate Similarity NPC183441
0.8132 Intermediate Similarity NPC241847
0.8132 Intermediate Similarity NPC473686
0.8132 Intermediate Similarity NPC221140
0.8132 Intermediate Similarity NPC229817
0.8132 Intermediate Similarity NPC475220
0.8132 Intermediate Similarity NPC475352
0.8118 Intermediate Similarity NPC472807
0.8118 Intermediate Similarity NPC477736
0.8111 Intermediate Similarity NPC72783
0.8108 Intermediate Similarity NPC470199
0.8108 Intermediate Similarity NPC314459
0.8103 Intermediate Similarity NPC97574
0.8103 Intermediate Similarity NPC93172
0.8103 Intermediate Similarity NPC120012
0.8103 Intermediate Similarity NPC100420
0.8101 Intermediate Similarity NPC289876
0.8101 Intermediate Similarity NPC231787
0.8098 Intermediate Similarity NPC314672
0.8095 Intermediate Similarity NPC231668
0.8092 Intermediate Similarity NPC477627
0.809 Intermediate Similarity NPC65118
0.8087 Intermediate Similarity NPC294863
0.8087 Intermediate Similarity NPC282636
0.8077 Intermediate Similarity NPC224557
0.8077 Intermediate Similarity NPC75574
0.8077 Intermediate Similarity NPC292706
0.807 Intermediate Similarity NPC10945
0.8068 Intermediate Similarity NPC128403
0.8068 Intermediate Similarity NPC302392
0.8066 Intermediate Similarity NPC477860
0.8066 Intermediate Similarity NPC475161
0.8059 Intermediate Similarity NPC469771
0.8059 Intermediate Similarity NPC477735
0.8054 Intermediate Similarity NPC48474
0.8049 Intermediate Similarity NPC204644
0.8047 Intermediate Similarity NPC48671
0.8047 Intermediate Similarity NPC473773
0.8047 Intermediate Similarity NPC475579
0.8045 Intermediate Similarity NPC475244
0.8045 Intermediate Similarity NPC223735
0.8045 Intermediate Similarity NPC307754
0.8043 Intermediate Similarity NPC205721
0.8036 Intermediate Similarity NPC327962
0.8036 Intermediate Similarity NPC162569
0.8036 Intermediate Similarity NPC116292
0.8036 Intermediate Similarity NPC267469
0.8036 Intermediate Similarity NPC12006
0.8036 Intermediate Similarity NPC179128
0.8036 Intermediate Similarity NPC35160
0.8036 Intermediate Similarity NPC87630
0.8034 Intermediate Similarity NPC474522
0.8034 Intermediate Similarity NPC470714
0.8034 Intermediate Similarity NPC470715
0.8034 Intermediate Similarity NPC470716
0.8033 Intermediate Similarity NPC87583
0.8033 Intermediate Similarity NPC33083
0.8024 Intermediate Similarity NPC477483
0.8024 Intermediate Similarity NPC325032
0.8023 Intermediate Similarity NPC268602
0.8023 Intermediate Similarity NPC266545
0.8023 Intermediate Similarity NPC202428
0.8023 Intermediate Similarity NPC262872
0.8022 Intermediate Similarity NPC475662
0.8022 Intermediate Similarity NPC473717
0.8022 Intermediate Similarity NPC293227
0.8022 Intermediate Similarity NPC473631
0.8012 Intermediate Similarity NPC320734
0.8011 Intermediate Similarity NPC58538
0.8011 Intermediate Similarity NPC187441
0.8011 Intermediate Similarity NPC200726
0.8011 Intermediate Similarity NPC306475
0.8011 Intermediate Similarity NPC283980
0.8 Intermediate Similarity NPC201814
0.8 Intermediate Similarity NPC227297
0.8 Intermediate Similarity NPC471874
0.8 Intermediate Similarity NPC25889
0.8 Intermediate Similarity NPC25491
0.7989 Intermediate Similarity NPC72554
0.7989 Intermediate Similarity NPC471493
0.7989 Intermediate Similarity NPC473467
0.7989 Intermediate Similarity NPC30011
0.7989 Intermediate Similarity NPC203751
0.7989 Intermediate Similarity NPC475197
0.7989 Intermediate Similarity NPC97817
0.7989 Intermediate Similarity NPC168789
0.7988 Intermediate Similarity NPC472022
0.7988 Intermediate Similarity NPC472005
0.7988 Intermediate Similarity NPC265395
0.7988 Intermediate Similarity NPC237549
0.7988 Intermediate Similarity NPC158333
0.7988 Intermediate Similarity NPC473414
0.7988 Intermediate Similarity NPC256142
0.7988 Intermediate Similarity NPC472030
0.7988 Intermediate Similarity NPC118033
0.7988 Intermediate Similarity NPC257213
0.7988 Intermediate Similarity NPC304876
0.7988 Intermediate Similarity NPC475379
0.7988 Intermediate Similarity NPC1173
0.7988 Intermediate Similarity NPC249471
0.7988 Intermediate Similarity NPC242262
0.7979 Intermediate Similarity NPC3474
0.7978 Intermediate Similarity NPC249560
0.7978 Intermediate Similarity NPC106700
0.7978 Intermediate Similarity NPC52598
0.7978 Intermediate Similarity NPC223860
0.7978 Intermediate Similarity NPC193698
0.7978 Intermediate Similarity NPC164704

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC124828 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8202 Intermediate Similarity NPD8313 Approved
0.8202 Intermediate Similarity NPD8312 Approved
0.8187 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD8455 Phase 2
0.7921 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7869 Intermediate Similarity NPD8434 Phase 2
0.7824 Intermediate Similarity NPD7458 Discontinued
0.7814 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7228 Approved
0.7747 Intermediate Similarity NPD7808 Phase 3
0.7692 Intermediate Similarity NPD7251 Discontinued
0.7692 Intermediate Similarity NPD7240 Approved
0.7688 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7668 Intermediate Similarity NPD7435 Discontinued
0.7637 Intermediate Similarity NPD6797 Phase 2
0.7629 Intermediate Similarity NPD8320 Phase 1
0.7629 Intermediate Similarity NPD8319 Approved
0.7584 Intermediate Similarity NPD8127 Discontinued
0.7582 Intermediate Similarity NPD7074 Phase 3
0.7569 Intermediate Similarity NPD7799 Discontinued
0.7569 Intermediate Similarity NPD3751 Discontinued
0.7563 Intermediate Similarity NPD8151 Discontinued
0.7543 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD3787 Discontinued
0.7525 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD7874 Approved
0.7514 Intermediate Similarity NPD7075 Discontinued
0.7514 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD7696 Phase 3
0.7487 Intermediate Similarity NPD7697 Approved
0.7487 Intermediate Similarity NPD7698 Approved
0.7486 Intermediate Similarity NPD37 Approved
0.7486 Intermediate Similarity NPD7472 Approved
0.7459 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD4967 Phase 2
0.7458 Intermediate Similarity NPD4966 Approved
0.7458 Intermediate Similarity NPD4965 Approved
0.7456 Intermediate Similarity NPD4628 Phase 3
0.7456 Intermediate Similarity NPD8166 Discontinued
0.7449 Intermediate Similarity NPD7870 Phase 2
0.7449 Intermediate Similarity NPD7871 Phase 2
0.7446 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD7054 Approved
0.7424 Intermediate Similarity NPD7701 Phase 2
0.7423 Intermediate Similarity NPD6777 Approved
0.7423 Intermediate Similarity NPD6781 Approved
0.7423 Intermediate Similarity NPD6779 Approved
0.7423 Intermediate Similarity NPD6776 Approved
0.7423 Intermediate Similarity NPD6778 Approved
0.7423 Intermediate Similarity NPD6780 Approved
0.7423 Intermediate Similarity NPD6782 Approved
0.741 Intermediate Similarity NPD7097 Phase 1
0.7405 Intermediate Similarity NPD6559 Discontinued
0.7405 Intermediate Similarity NPD7685 Pre-registration
0.74 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7783 Phase 2
0.7394 Intermediate Similarity NPD8150 Discontinued
0.7374 Intermediate Similarity NPD6234 Discontinued
0.7371 Intermediate Similarity NPD6599 Discontinued
0.7345 Intermediate Similarity NPD7819 Suspended
0.732 Intermediate Similarity NPD7699 Phase 2
0.732 Intermediate Similarity NPD7700 Phase 2
0.7313 Intermediate Similarity NPD7801 Approved
0.7312 Intermediate Similarity NPD8368 Discontinued
0.7308 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD6801 Discontinued
0.7278 Intermediate Similarity NPD7266 Discontinued
0.7273 Intermediate Similarity NPD4380 Phase 2
0.7268 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD6166 Phase 2
0.7246 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD6190 Approved
0.7198 Intermediate Similarity NPD7199 Phase 2
0.7196 Intermediate Similarity NPD8407 Phase 2
0.7189 Intermediate Similarity NPD3818 Discontinued
0.7186 Intermediate Similarity NPD6355 Discontinued
0.7184 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD6534 Approved
0.7165 Intermediate Similarity NPD6535 Approved
0.7151 Intermediate Similarity NPD5844 Phase 1
0.7151 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7003 Approved
0.7143 Intermediate Similarity NPD6273 Approved
0.7135 Intermediate Similarity NPD7473 Discontinued
0.7126 Intermediate Similarity NPD6799 Approved
0.7126 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD5402 Approved
0.7111 Intermediate Similarity NPD3817 Phase 2
0.7111 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD6798 Discontinued
0.7104 Intermediate Similarity NPD6959 Discontinued
0.7093 Intermediate Similarity NPD6674 Discontinued
0.7085 Intermediate Similarity NPD6823 Phase 2
0.7081 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD7236 Approved
0.7066 Intermediate Similarity NPD6233 Phase 2
0.7065 Intermediate Similarity NPD6232 Discontinued
0.7056 Intermediate Similarity NPD5761 Phase 2
0.7056 Intermediate Similarity NPD5760 Phase 2
0.7053 Intermediate Similarity NPD8404 Phase 2
0.7052 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD7680 Approved
0.7048 Intermediate Similarity NPD7095 Approved
0.7047 Intermediate Similarity NPD8435 Approved
0.7039 Intermediate Similarity NPD7411 Suspended
0.7037 Intermediate Similarity NPD6764 Approved
0.7037 Intermediate Similarity NPD6765 Approved
0.702 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5403 Approved
0.6989 Remote Similarity NPD5401 Approved
0.6985 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6978 Remote Similarity NPD7768 Phase 2
0.6977 Remote Similarity NPD5762 Approved
0.6977 Remote Similarity NPD5763 Approved
0.6966 Remote Similarity NPD7239 Suspended
0.6959 Remote Similarity NPD8361 Approved
0.6959 Remote Similarity NPD8360 Approved
0.6957 Remote Similarity NPD5494 Approved
0.6943 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6927 Remote Similarity NPD3226 Approved
0.6914 Remote Similarity NPD8328 Phase 3
0.691 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6891 Remote Similarity NPD6784 Approved
0.6891 Remote Similarity NPD6785 Approved
0.6889 Remote Similarity NPD7028 Phase 2
0.6881 Remote Similarity NPD7497 Discontinued
0.6868 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6853 Remote Similarity NPD6212 Phase 3
0.6853 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6853 Remote Similarity NPD6213 Phase 3
0.6834 Remote Similarity NPD8485 Approved
0.6833 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6824 Remote Similarity NPD4060 Phase 1
0.6813 Remote Similarity NPD1934 Approved
0.6805 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6798 Remote Similarity NPD2534 Approved
0.6798 Remote Similarity NPD2532 Approved
0.6798 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6798 Remote Similarity NPD2533 Approved
0.6798 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6793 Remote Similarity NPD3882 Suspended
0.6782 Remote Similarity NPD2346 Discontinued
0.6778 Remote Similarity NPD1653 Approved
0.6776 Remote Similarity NPD1465 Phase 2
0.6765 Remote Similarity NPD8032 Phase 2
0.6763 Remote Similarity NPD2799 Discontinued
0.6763 Remote Similarity NPD7033 Discontinued
0.675 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6743 Remote Similarity NPD970 Clinical (unspecified phase)
0.6743 Remote Similarity NPD4534 Discontinued
0.6732 Remote Similarity NPD7999 Approved
0.6725 Remote Similarity NPD4140 Approved
0.6724 Remote Similarity NPD6100 Approved
0.6724 Remote Similarity NPD6099 Approved
0.6724 Remote Similarity NPD2935 Discontinued
0.6724 Remote Similarity NPD2438 Suspended
0.6714 Remote Similarity NPD7930 Approved
0.6704 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6702 Remote Similarity NPD7229 Phase 3
0.6667 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6677 Suspended
0.6667 Remote Similarity NPD4062 Phase 3
0.6667 Remote Similarity NPD3749 Approved
0.6667 Remote Similarity NPD3750 Approved
0.6667 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4110 Phase 3
0.665 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6648 Remote Similarity NPD1549 Phase 2
0.6647 Remote Similarity NPD8651 Approved
0.6646 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6631 Remote Similarity NPD919 Approved
0.6629 Remote Similarity NPD2796 Approved
0.6627 Remote Similarity NPD1608 Approved
0.6613 Remote Similarity NPD7057 Phase 3
0.6613 Remote Similarity NPD7058 Phase 2
0.6611 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6611 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6606 Remote Similarity NPD8059 Phase 3
0.6606 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6595 Remote Similarity NPD2801 Approved
0.6591 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6591 Remote Similarity NPD1550 Clinical (unspecified phase)
0.659 Remote Similarity NPD5735 Approved
0.6582 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6576 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6571 Remote Similarity NPD3748 Approved
0.6571 Remote Similarity NPD1510 Phase 2
0.657 Remote Similarity NPD6663 Approved
0.6568 Remote Similarity NPD2798 Approved
0.6566 Remote Similarity NPD1091 Approved
0.6554 Remote Similarity NPD5958 Discontinued
0.655 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6548 Remote Similarity NPD1283 Approved
0.6538 Remote Similarity NPD7584 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data